MedTrace Logo

Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00004100 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2013-12-18

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of chemotherapy is more effective for non-small cell lung cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of chemotherapy in treating patients who have stage IIIB or stage IV non-small cell lung cancer.

Conditions

Interventions

DRUG

cisplatin

DRUG

gemcitabine hydrochloride

DRUG

vinorelbine tartrate

Sponsors & Collaborators

  • NCIC Clinical Trials Group

    collaborator NETWORK

  • Istituto Nazionale per lo Studio e la Cura dei Tumori

    lead OTHER

Principal Investigators

  • Cesare Gridelli, MD · Istituto Nazionale per lo Studio e la Cura dei Tumori

  • Vera Hirsh, MD, FRCPC · Royal Victoria Hospital - Montreal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-11-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004100 on ClinicalTrials.gov